Qilin Zhou - Search Results

Year	Number of Results
2002	3
2003	3
2004	3
2005	4
2006	8
2007	8
2008	8
2009	4
2010	7
2011	8
2012	12
2013	9
2014	8
2015	11
2016	16
2017	16
2018	13
2019	15
2020	13
2021	16
2022	7
2023	18
2024	8

1

Visible-Light-Induced α,γ-C(sp³)-H Difunctionalization of Piperidines.

Wang B, Zhou MJ, Zhou QL. Wang B, et al. Org Lett. 2022 Apr 22;24(15):2894-2898. doi: 10.1021/acs.orglett.2c00831. Epub 2022 Apr 13. Org Lett. 2022. PMID: 35416677

2

Ketone α-alkylation at the more-hindered site.

Li MM, Zhang T, Cheng L, Xiao WG, Ma JT, Xiao LJ, Zhou QL. Li MM, et al. Nat Commun. 2023 Jun 7;14(1):3326. doi: 10.1038/s41467-023-38741-w. Nat Commun. 2023. PMID: 37286579 Free PMC article.

3

Enantioselective Silicon-Directed Nazarov Cyclization.

Cao J, Hu MY, Liu SY, Zhang XY, Zhu SF, Zhou QL. Cao J, et al. J Am Chem Soc. 2021 May 12;143(18):6962-6968. doi: 10.1021/jacs.1c01194. Epub 2021 Apr 28. J Am Chem Soc. 2021. PMID: 33909970

4

Nickel-Catalyzed Intramolecular Hydroalkenylation of Imines.

Feng WM, Li TY, Xiao LJ, Zhou QL. Feng WM, et al. Org Lett. 2021 Oct 15;23(20):7900-7904. doi: 10.1021/acs.orglett.1c02908. Epub 2021 Sep 24. Org Lett. 2021. PMID: 34559538

5

Transition metal-catalyzed enantioselective hydrogenation of enamines and imines.

Xie JH, Zhu SF, Zhou QL. Xie JH, et al. Chem Rev. 2011 Mar 9;111(3):1713-60. doi: 10.1021/cr100218m. Epub 2010 Dec 17. Chem Rev. 2011. PMID: 21166392 Review. No abstract available.

6

Total Synthesis of the Alleged Structure of (+)-Fimbricalyxoid A.

Li LP, Han JQ, Yang F, Wu X, Xie JH, Zhou QL. Li LP, et al. Org Lett. 2022 May 20;24(19):3477-3481. doi: 10.1021/acs.orglett.2c01076. Epub 2022 May 6. Org Lett. 2022. PMID: 35522037

7

Enantioselective Total Syntheses of Pentacyclic Homoproaporphine Alkaloids.

Pu LY, Yang F, Chen JQ, Xiong Y, Bin HY, Xie JH, Zhou QL. Pu LY, et al. Org Lett. 2020 Oct 2;22(19):7526-7530. doi: 10.1021/acs.orglett.0c02720. Epub 2020 Sep 16. Org Lett. 2020. PMID: 32937077

8

Enantioselective Total Synthesis of (-)-Hamigeran F and Its Rearrangement Product.

Xiong Y, Chen YH, Li T, Xie JH, Zhou QL. Xiong Y, et al. Org Lett. 2022 Jul 22;24(28):5161-5165. doi: 10.1021/acs.orglett.2c01997. Epub 2022 Jul 11. Org Lett. 2022. PMID: 35816023

9

SUMO2/3 promotes the progression and oxaliplatin resistance of colorectal cancer through facilitating the SUMOylation at Ku80-K307.

Feng D, He J, Yuan M, Chen Q, Zeng X, Zhou Q, Wu J, Han B. Feng D, et al. Among authors: zhou q. Biofactors. 2023 Nov-Dec;49(6):1158-1173. doi: 10.1002/biof.1984. Epub 2023 Jun 20. Biofactors. 2023. PMID: 37338025

10

Transition-Metal Catalysis and Organocatalysis: Where Can Progress Be Expected?

Zhou QL. Zhou QL. Angew Chem Int Ed Engl. 2016 Apr 25;55(18):5352-3. doi: 10.1002/anie.201509164. Epub 2015 Dec 14. Angew Chem Int Ed Engl. 2016. PMID: 26662619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

193 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year